First Trust Advisors LP lifted its holdings in Humana Inc. (NYSE:HUM) by 30.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 85,419 shares of the insurance provider’s stock after purchasing an additional 20,037 shares during the quarter. First Trust Advisors LP owned 0.06% of Humana worth $20,811,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. WFG Advisors LP lifted its position in Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after buying an additional 20 shares during the last quarter. Acrospire Investment Management LLC bought a new stake in Humana in the second quarter worth $120,000. Independent Portfolio Consultants Inc. lifted its position in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares during the last quarter. Finally, Fiduciary Trust Co. bought a new stake in Humana in the second quarter worth $135,000. 95.79% of the stock is owned by hedge funds and other institutional investors.
Humana Inc. (NYSE:HUM) opened at $256.69 on Friday. Humana Inc. has a 52 week low of $165.52 and a 52 week high of $264.56. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $37,096.07, a PE ratio of 22.30, a price-to-earnings-growth ratio of 1.66 and a beta of 0.91.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the previous year, the firm earned $2.30 earnings per share. equities research analysts expect that Humana Inc. will post 11.57 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.62%. Humana’s dividend payout ratio (DPR) is presently 13.06%.
A number of analysts recently issued reports on HUM shares. Piper Jaffray Companies restated a “buy” rating and issued a $246.00 price target on shares of Humana in a research report on Friday, July 14th. Cowen and Company restated a “buy” rating and issued a $230.00 price target on shares of Humana in a research report on Friday, July 14th. Bank of America Corporation raised their price target on Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. ValuEngine upgraded Humana from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Finally, Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $273.00 price target for the company in a research report on Tuesday, October 3rd. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $253.71.
In other Humana news, VP M Todoroff Christopher sold 22,935 shares of Humana stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the transaction, the vice president now owns 24,001 shares in the company, valued at $6,060,732.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of Humana stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $259.00, for a total value of $2,534,574.00. Following the completion of the transaction, the insider now owns 18,042 shares in the company, valued at approximately $4,672,878. The disclosure for this sale can be found here. Insiders sold 55,595 shares of company stock worth $14,133,706 in the last quarter. 0.80% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.com-unik.info/2017/11/05/first-trust-advisors-lp-acquires-20037-shares-of-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.